Essure-Related Complications Still A Problem, Latest FDA Data Show

More women have had the device removed

Interim data from two ongoing studies show more women have had the Essure birth control device removed while many are still experiencing adverse events, such as pain and bleeding.

ESSURE DEVICE
• Source: Alamy

Though no longer on the market, the Essure birth control device is still causing problems for many women who had them implanted, such as chronic abdominal pain, pelvic pain, and abnormal uterine bleeding. And many women are opting to have the devices removed.

Designed as an alternative to permanent birth control surgery, the tiny spring-like devices inserted into the fallopian tubes to block the fertilization of eggs received FDA-approval in 2002. However, after...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.